Abstract: Objective The aim of the present study was to determine the changes in the mRNA levels of neurotrophins and their receptors in the striatal tissue of mice treated with 3-nitropropionic acid (3-NP). Methods At 1 and 48 h after the last drug administration, the mRNA expression of nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 as well as their receptors p75, TrkA, TrkB and TrkC, was evaluated using semi-quantitative (semi-Q) and real-time RT-PCR. β-actin mRNA and ribosomal 18S (18S rRNA) were tested as internal controls. Results 3-NP treatment did not affect mRNA expression of all neurotrophins and their respective receptors equally. Also, differences in neurotrophin and receptor mRNA expression were observed between semi-Q and real-time RT-PCR. Real-time RT-PCR was more accurate in evaluating the mRNA expression of the neurotrophins than semi-Q, and 18S rRNA was more reliable than β-actin as an internal control. Conclusion Neurotrophins and their receptors expression is differentially affected by neuronal damage produced by inhibition of mitochondrial respiration with 3-NP treatment in low, sub-chronic doses in vivo.
Introduction
Neurotrophins are growth factors that regulate the cellular and molecular mechanisms involved in the development and maintenance of the nervous system [1] . In the mature nervous system, they play a major role in neuronal protection and the maintenance of cellular homeostasis; therefore, any change in their expression could be associated with neurodegeneration [2] .
There are difficulties in assessing the expression of neurotrophins in the nervous system; for example, in early reports, brain-derived neurotrophic factor (BDNF) mRNA was not detected in striatal tissue by in situ hybridization [3] , but soon after, nerve growth factor (NGF), BDNF, neurotrophin-3 (NT-3) [4] and NT-4/5 [5] mRNA expression was described using the RNAse protection assay, and in most of these experiments glyceraldehyde dehydrogenase (GAPDH) was selected as the control gene.
Another problem hindering the evaluation of neurotrophin expression is that the amount of mRNA or protein obtained can be misinterpreted. Furthermore, the type of reverse transcriptase-polymerase chain reaction (RT-PCR) technique used and the selection of the internal control gene are important for the assessment of neurotrophin mRNA. The gene used as an internal control should not vary under experimental conditions [6] . Internal controls commonly used include β-actin, β-2-globulin, β-tubulin, GAPDH and 18S rRNA [7] .
The expression levels of neurotrophins and their receptors change in the presence of neuronal damage, e.g., after excitotoxic lesioning of the striatum [4, 8, 9] .
Mitochondrial dysfunction is known to underlie the cellular mechanisms in neurodegeneration [10] ; indeed, the application of mitochondrial toxins mimics the degeneration exhibited in Huntington disease (HD). For example, 3-nitropropionic acid (3-NP) induces striatal neuronal damage in humans and experimental animals [11, 12] . This mitochondrial toxin inhibits mitochondrial complex II in the respiratory chain, reduces ATP synthesis, increases Ca 2+ influx, and activates proteases that cause cellular damage and the death of medium spiny neurons [12] [13] [14] . In previous experiments we showed that systemic administration of low sub-chronic doses of 3-NP to C57/BL6 mice is enough to initiate damage of calbindin-positive neurons in the striatum [15] [16] [17] .
As neurotrophin levels are altered in animal models of HD, and 3-NP administration mimics the histopathology of HD, we aimed to evaluate changes in neurotrophin mRNA expression after sub-chronic (5-day) intraperitoneal 3-NP treatment at a low dose, to mimic early neuronal damage.
mRNA expression was evaluated at 1 and 48 h after the final dose of 3-NP using semi-quantitative (semi-Q) RT-PCR and real-time RT-PCR. To select the internal control for gene expression, we avoided GAPDH because in previous experiments, we found changes in its expression in the striatum after 3-NP treatment [15] . Instead, two genes, β-actin due to its stable expression in mouse models of neurodegeneration [18] and 18S rRNA (a gene encoding a small subunit of the 18S ribosome) due to its stability in the mouse brain and other tissues [7, 19] , were tested as internal controls. 3-NP was dissolved in PB and pH adjusted with NaOH.
Materials and methods

Animals
Tissue harvest
The mice were sacrificed 1 or 48 h after the final treatment. The brain was removed under halothane anesthesia, and the striatal tissue was dissected out and kept at −70 °C for total RNA extraction.
RNA extraction and RT-PCR
Total RNA was isolated from 0.5-g samples of frozen striatal tissue (3) (4) (5) (6) brains from each experimental condition). RNA extraction was carried out using the TRIzol reagent method modified for cerebral tissue using the Total RNA Isolation Reagent (Invitrogen Life Technologies Inc., Carlsbad, CA) and precipitation with ethanol. The RNA concentration was calculated from the optical density at 260 nm, and the purity was determined by measuring the 260/280 nm absorbance ratio. cDNA was generated from 1.5 μg/μL of total RNA with a mix of oligo (dT) 12-18 and random hexamer primers using a SuperScript I RT kit (Invitrogen Life Technologie Inc.). The reaction was performed on a Techne TC3000 thermocycler, at 37 °C for 60 min. cDNAs were kept at −20 °C before use. The primers and PCR conditions for NGF, BDNF, NT-3,
Semi-Q RT-PCR
NT-4/5, TrkA, TrkB, TrkC, 18S rRNA and β-actin are reported elsewhere [20, 21] and listed in Table 1 . PCR products were subjected to electrophoresis on a 2% agarose gel, and stained with ethidium bromide (Sigma-Aldrich). The area and density of the PCR product bands were measured by chemoluminescence using a Fujifilm FLA-5000 scanner and digitized with the Image Reader FLA-5000 V2.1 program. The control mRNA level served as an internal standard to ensure equal loading of RNA, and neurotrophin mRNA levels were normalized to those of the internal control. The resulting measurements were expressed as arbitrary densitometric units and statistically analyzed. , and normalized to 18S rRNA expression.
Real-time PCR
Terminal deoxynucleotidyl transferase dUTP
nick-end labeling (TUNEL) assay TUNEL assay was carried out to evaluate apoptotic damage in the cortex The nucleotide sequences used to assay gene expression were determined according to those previously reported [20, 21] . All primers were synthesized by SigmaAldrich Inc., St. Louis, MO. TrkB-, truncated isoform; TrkB+, full-length isoform.
above the dorsal striatum. The assay was performed at 48 h after the last dose following the methodology in our previous report [15] using an apoptosis detection kit 
Data analysis
Results
Selection of the internal control β-actin mRNA and
18S rRNA were tested as internal controls ( 
-test). This result
suggested that 18S rRNA was a good internal control for our study. The relative expression levels of neurotrophins and their receptors were normalized to each of the internal controls (β-actin and 18S). Significant differences were obtained upon comparison of the relative expression in the control group normalized to β-actin and that in the control group normalized to 18S rRNA at 1 h ( Fig. 2A, C ) and 48 h after the final dose ( Fig. 2B, D ; Table 2 ).
The expression of neurotrophins, Trks, and p75 receptors normalized to b-actin was higher than that normalized to 18S in striatal tissue from 3-NP treated mice 1 h after the final administration (Fig. 2E, G) , and their expression exhibited discrete differences at 48 h after the final dose when 
Similar comparisons were made in the 3-NP treatment group (E-H). Note that the relative mRNA expression of the neurotrophins and their recep-
tors was overestimated when normalized to β-actin. *P <0.05, **P <0.01, ***P <0.001. TrkB+, full-length isoform; TrkB-, truncated isoform.
normalized to β-actin or 18S rRNA ( Fig. 2F, H ; Table 2 ). 
Neurotrophin gene expression in the striatum
Neurotrophin receptor gene expression in the striatum after 3-NP/vehicle treatment: Semi-Q RT-PCR
The expression of neurotrophin receptor mRNA, normalized to either β-actin or 18S rRNA, was not statistically different between 3-NP and control groups at the evaluated times (Fig. 4) . Moreover, mRNA expression of TrkB was evaluated in full-length (TrkB+) and truncated (TrkB-) isoforms.
Neurotrophin
TrkB+ showed no differences between the groups at either time point (1 h, t 3 = 1.348, P = 0.270, Fig. 7E ; 48 h, t 8 = −1.571, P = 0.155; t-test; Fig. 7F ). TrkB-showed a slight, but insignificant increase in mRNA expression at both 1 and 48 h after the last dose (t 3 = −1.743, P = 0.180, Fig.   7G ; t 9 = −1.729, P = 0.118, Fig. 7H ; respectively). All the results of quantitative real-time PCR evaluation of neurotrophin and receptor mRNA expression in the striatum after 3-NP treatment are summarized in Table 3 .
NT-3 and the TrkC receptor
As a lack of neurotrophic factors like BDNF in the cortico-striatal pathway induces cell damage, TUNEL assay was performed to document this. 3-NP increased the number of apoptotic cells in the striatum and, to a lesser extent, in the cortex at 48 h after the last dose (Fig. 9 ).
Discussion
The results of the present study showed that systemic administration of 3-NP induced cell damage, and differen- 
BDNF (E, F), NT-3 (G, H), and NT-4/5 (I, J). Normalization to 18S rRNA or β-actin is indicated in each graph.
Semi-Q PCR versus quantitative RT-PCR The
PCR technique is ideal for detecting changes in gene expression through measurement of the mRNA abundance corresponding to specific genes in different physiological states [22] . However, accurate results depend on the technique used. The results obtained in the present study differed depending on which technique was used and which gene was selected as an internal control.
The Semi-Q RT-PCR method was less sensitive in estimating low levels of mRNA, and it overestimated gene expression levels generated as increased expression of neurotrophin mRNAs after 3-NP treatment. Conversely, quantitative RT-PCR showed significant changes in the relative expression levels of BDNF, NT-3, TrkA, TrkC and p75 mRNA, confirming that this method is more sensitive in estimating subtle changes in the expression of specific genes [23, 24] , such as those of the neurotrophins.
The difference between semi-Q RT-PCR and quantitative RT-PCR is well recognized [25] ; however, as much of the information related to neurotrophin mRNA expression in the striatum was obtained with semi-Q RT-PCR or in situ hybridization, we used this as a reference for comparison with previous reports in the same region [3] [4] [5] . We are aware that the primers used in the present study were designed for semi-Q RT-PCR [20, 21] . However, in our experimental conditions they worked with the same efficiency for quantitative RT-PCR, showing efficient amplification and one single product.
Selection of reference genes
To address errors in the estimation of cDNA amplification, the relative quantification is normalized to the expression of an internal control template in a control sample; this manipulation reduces experimental error [26] . An ideal reference gene would have consistent, non-regulated and independent expression.
Commonly-used internal controls include those involved in vital functions of the cell such as metabolism (GAPDH) or cell structure (actin or tubulin); however, not all internal controls are abundant or expressed homogenously throughout the organism [18, 27] . We previously demonstrated that GAPDH levels vary with the experimental protocol [15] , therefore we evaluated β-actin and ribosomal 18S in the present study.
Although β-actin is a common internal control in RT-
PCR studies of the nervous system, there is much evidence pointing out its inconvenience [18] . In the present study, we found that β-actin mRNA expression was unstable and heterogeneous throughout all experimental conditions. In addition, β-actin expression has been shown to vary among different regions in the brain [18] and therefore is not always a good control [28] . With regard to our results, it is known that the transport of β-actin mRNA is controlled by neurotrophins; therefore, if 3-NP affects neurotrophin expression, it also affects β-actin transport [29] , which may change its final expression.
Adoption of the housekeeping gene 18S rRNA as ref-
erence is strongly supported by other studies [7, 27, 28, 30] . After 18S rRNA was shown to be more reliable as a control gene and random hexamers for the reverse-transcription reaction [30] to guarantee its hybridization. expression were observed only 6 h after an excitotoxic lesion [4] or one week after a mechanical injury [31] . The lack of early changes (less than 6 h after lesion) in neurotrophin mRNA expression has also been reported in other neuronal populations [32] . In the present study, greatest changes were detected at 48 h after the last dose, suggesting that damage is progressive and that low sub-chronic doses of 3-NP mimics the progression of neurodegeneration very well. erence genes, confirming that this method is less sensitive when the cellular target is expressed at low levels [23] .
Early
Neurotrophin
With regard to NGF, it is possible that its increased mRNA expression is associated with striatal neurodegeneration and/or the provision of trophic support [33, 34] , although overestimation of NGF mRNA levels can be attributed to the PCR method. this does not always correspond to the optimal efficiency of the reaction and therefore is less precise [25] .
The relative expression of TrkA mRNA increased significantly in the 3-NP group at 48 h after the last dose.
The differential expression pattern between TrkA receptors and their endogenous ligand indicates that when neuronal damage occurs, NGF-sensitive cells may require additional available receptors; an increase in the number of receptors potentially triggers signaling to facilitate the survival of NGF-sensitive neurons [35] . In the striatum, the NGFresponsive cells are cholinergic interneurons [4, 8] , and our results confirmed that 3-NP does not affect all striatal cell populations equally. [4, 36] . Our BDNF results are also consistent with numerous studies carried out in animal models of HD under different experimental conditions [37] [38] [39] and in postmortem studies of HD patients [40] , suggesting that attenuation of BDNF leads to the selective death of striatal neurons and contributes to the development of HD pathology [36] . We provided evidence of how 3-NP treatment may affect BDNF levels in the striatum; TUNEL assays showed that not only striatal, but also cortical cells showed 3-NPinduced apoptotic damage. As BDNF is synthesized in the cortex, any damage in the cortico-striatal pathway reduces cortico-striatal trophic support, leading to striatal degeneration.
In contrast to the effects on BDNF, 3-NP did not change NT-4/5 mRNA expression at the evaluated times.
Similar to BDNF, NT-4/5 binds to TrkB receptors, and the neuronal protection provided by both neurotrophins depends on TrkB receptor expression [41] and activation of the full-length TrkB isoform, which has tyrosine kinase activity [42] . In this regard, we did not find a significant change in proposed that NT-4/5 can replace BDNF deficiency to promote the survival [43] of specific striatal neuronal populations [44] . We have demonstrated that NT-4/5 becomes detectable in striatal cells after BDNF during postnatal development [45] , and since there is no evidence that it comes from the cortex, it is possible that NT-4/5 is produced by cells that are not as sensitive to 3-NP as those that respond to BDNF. administration. This increase suggests that NT-3 plays an important trophic role in striatal function. NT-3 may be released into the striatum from corticostriatal afferents [45] and protect striatal cells [46] by activating the TrkC receptor and MAPK/ERK and PI-3K/Ark signaling pathways [41] .
NT-3 is able to bind to the other TrK receptors, so if NT-3 is over-expressed, it could bind to TrkA and TrkB receptors and trigger alternative signaling pathways to promote cell survival or regeneration [41, 46] . The level of TrkC receptor mRNA also increased at 48 h, which supports the hypothesis that TrkC and NT-3 play a neuroprotective role in the striatum. However, the TrkC receptor increase could be associated with apoptosis induction, as proposed elsewhere [46, 47] . We have evidence that 3-NP administered as in the present study triggers apoptosis; hence a TrkC increase due to apoptosis cannot be ruled out. Trk receptors [48] and, depending on the cellular context, its expression varies. For example, p75 expression is reduced during development [49] , but in the mature nervous system its increase is associated with caspase activation [9, 50] and cellular damage [51] . As such, the p75 expression increases in our experimental conditions may be related to the striatal apoptotic injury documented in Fig. 9 ; more experiments are needed to test this idea.
Conclusion
The present study shows that the expression of neurotrophins and their receptors is differentially affected by neuronal damage induced by inhibition of mitochondrial respiration with 3-NP in low sub-chronic doses in vivo.
Our data also show that 18S rRNA can be used as a reference gene for studies of neurotrophin expression in the striatum when the underlying damage is related to mitochondrial dysfunction. Furthermore, β-actin and GAPDH should be avoided in 3-NP studies because their use may affect the accuracy of gene expression results.
